Hejing Biotech (688068.SH) issued an announcement. As of May 7, 2024, the company has completed the repurchase and passed...
Zhitong Finance App News, Hotview Biotech (688068.SH) announced that as of May 7, 2024, the company had completed the repurchase. Through centralized bidding, the company had repurchased a total of 2.893 million shares, accounting for 3.13% of the company's total share capital. The highest price of the repurchase transaction was 33.79 yuan/share, the lowest price was 27.28 yuan/share, and the total amount of capital paid was RMB 92.65 million (excluding transaction fees such as stamp duty and transaction commissions).